Utilities Registry – Page 4 – Center for Health Decision Science

Filter results using search terms, or by selecting one or more valuation, condition, or population.

Valuation

Population

Condition

Viewing 31 - 40 of 44 results

Title	Year(s) of data collection	Valuation Method	Country	Condition
Selection of general population health health state utilities (Nikl A et al., Health Qual Life Outcomes. 2023. doi:10.1186/s12955-023-02096-z)	2021	15D, EQ-5D-5L	Hungary	General population health
DOI 10.7910/DVN/OE5E2K Author(s) Registry, Utilities Description Health state utilities for general population health conditions Sample Characteristics 1887 participants in the online cross-sectional survey
Title Selection of orthopedic and musculoskeletal health state utilities (Kontodimopoulos N et al., J Clin Med. 2022. doi:10.3390/jcm11144097)	Year(s) of data collection 2020	Valuation Method EQ-5D-3L, EQ-5D-5L, SF-6D	Country Greece	Condition Ankylosing spondylities, Musculoskeletal disorders, Osteopenia/Osteporosis, Psoriaticc arthritis, Rheumatiod arthritis
DOI 10.7910/DVN/VR4XYO Author(s) Registry, Utilities Description Health state utilities for orthopedic and musculoskeletal conditions Sample Characteristics A cross-sectional sample of 315 (total) consecutive patients clinically diagnosed with RA, PsA, AS, or OsP/OP
Title Selection of oncology health state utilities (Katanyoo K et al., Expert Rev Pharmacoecon Outcomes Res. 2022. doi:10.1080/14737167.2021.1906224)	Year(s) of data collection 2019	Valuation Method EQ-5D-3L, EQ-5D-5L, TTO	Country Thailand	Condition Cervical cancer
DOI 10.7910/DVN/L4V2LU Author(s) Registry, Utilities Description Health state utilities for oncology conditions Sample Characteristics 194 cross-sectional study patients with locally advanced cervical cancer
Title Selection of autoimmune disease health state utilities (Dewilde S et al., Adv Ther. 2023. doi:10.1007/s12325-023-02437-w)	Year(s) of data collection 2021	Valuation Method EQ-5D-5L, HUI3	Country Belgium, Canada, Denmark, France, Germany, Italy, Japan, Netherlands, Spain, United Kingdom of Great Britain and Northern Ireland, United States of America	Condition Myasthenia gravis
DOI 10.7910/DVN/XTLOGB Author(s) Registry, Utilities Description Health state utilities for autoimmune disease conditions Sample Characteristics 9000 participants in the general population norms study that included adult patients with gMG randomly assigned to treatment with efgartigimod or conventional therapy
Title Selection of autoimmune disease health state utilities (Dewilde S et al., Adv Ther. 2023. doi:10.1007/s12325-023-02437-w)	Year(s) of data collection 2019 - 2022	Valuation Method EQ-5D-5L, HUI3	Country Canada, Denmark, France, Germany, Italy, Japan, Spain, United Kingdom of Great Britain and Northern Ireland, United States of America	Condition Myasthenia gravis
DOI 10.7910/DVN/XTLOGB Author(s) Registry, Utilities Description Health state utilities for autoimmune disease conditions Sample Characteristics 1299 participants (EQ-5D-5L) and 549 participants (HUI3) from MyRealWorld-MG study
Title Selection of orthopedic and musculoskeletal health state utilities (Li N et al., J Med Econ. 2022. doi:10.1080/13696998.2022.2087409)	Year(s) of data collection 2014 - 2016	Valuation Method EQ-5D-5L, SF-6D	Country Netherlands	Condition Fracture
DOI 10.7910/DVN/VR4XYO Author(s) Registry, Utilities Description Health state utilities for orthopedic and musculoskeletal conditions Sample Characteristics 499 participants in a prospective observational study in a Dutch Fracture Liaison Service clinic
Title Selection of general population health health state utilities (Xie S et al., Eur J Health Econ. 2023. doi:10.1007/s10198-023-01566-x)	Year(s) of data collection 2019	Valuation Method EQ-5D-5L, SF-6Dv2	Country China	Condition General population health
DOI 10.7910/DVN/OE5E2K Author(s) Registry, Utilities Description Health state utilities for general population health conditions Sample Characteristics 3320 participants from the Chinese general population
Title Selection of general population health health state utilities (Teni FS et al., Qual Life Res. 2022. doi:10.1007/s11136-021-02982-3)	Year(s) of data collection 2017	Valuation Method EQ-5D-5L, TTO	Country Sweden	Condition General population health
DOI 10.7910/DVN/OE5E2K Author(s) Registry, Utilities Description Health state utilities for general population health conditions Sample Characteristics 25867 participants from the population-based health survey Life & Health 2017, a cross-sectional self-administered postal survey in the regions/county councils in mid-Sweden
Title Selection of COVID-19 health state utilities (Philip KEJ et al. Lancet Respir Med. 2022. doi:10.1016/S2213-2600(22)00125-4)	Year(s) of data collection 2021	Valuation Method SF-6D	Country United Kingdom of Great Britain and Northern Ireland	Condition COVID-19
DOI 10.7910/DVN/MJ4J77 Author(s) Registry, Utilities Description Health state utilities for states related to COVID-19 Sample Characteristics 150 people in RCT of breathing and wellbeing programme for people with persistent symptoms following COVID-19
Title Selection of general population health health state utilities (McGrath A et al., Int J Environ Res Public Health. 2022. doi:10.3390/ijerph19042204)	Year(s) of data collection 2019	Valuation Method SF-6D	Country Ireland	Condition General population health
DOI 10.7910/DVN/OE5E2K Author(s) Registry, Utilities Description Health state utilities for general population health conditions Sample Characteristics 421 participants in the ‘Sheds for Life’, a 10-week men’s health initiative

← Previous results Next results →